-
THE ACCELERATED CLOCK: IS LESS TIME FAIR WHEN THE WORK IS THE SAME?
Aug 11, 2026, 17:16 PM -
ESTIMATING THE FISCAL COST OF STROKE IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
REGIONAL INEQUALITIES IN TIMELY ACCESS TO THE SPANISH NHS: EVIDENCE FROM A COMPOSITE INDEX (ISAT), 2023-2025
Aug 11, 2026, 17:16 PM -
HEALTH INEQUALITIES IN WOMEN'S HEALTH HTA: ARE NICE DECISIONS EQUITY-INFORMED?
Aug 11, 2026, 17:16 PM -
AGE SPECIFIC BALANCE OF BENEFITS AND HARMS FOR CANCER SCREENING PROGRAMS IN JAPAN
Aug 11, 2026, 17:16 PM -
ECONOMIC MODELING IN SYSTEMIC LUPUS ERYTHEMATOSUS - A SYSTEMATIC APPRAISAL OF PUBLISHED MODEL STRUCTURES AND EVIDENCE BASES
Aug 11, 2026, 17:16 PM -
DEVELOPING A PROOF-OF-CONCEPT WORKFLOW COMBINING AI-DRIVEN HTA COMMITTEE SIMULATION AND AI-GENERATED PAYER QUESTIONNAIRES FOR PROACTIVE PRICING AND ACCESS PLANNING
Aug 11, 2026, 17:16 PM -
PROJECTED WIDER SOCIETAL AND FISCAL IMPACT OF SEMAGLUTIDE IN THE UNITED KINGDOM
Aug 11, 2026, 17:16 PM -
COPD IN IRELAND THROUGH THE PATIENT LENS: REPORTED EXPERIENCES, PROGRESS, AND CHALLENGES
Aug 11, 2026, 17:16 PM -
BEYOND SINGLE-MODEL SURROGACY: A MULTI-MODEL EVALUATION OF PROGRESSION-FREE SURVIVAL AS A TRIAL-LEVEL SURROGATE FOR OVERALL SURVIVAL IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Aug 11, 2026, 17:16 PM -
OUTCOMES IN INFLUENZA PHASE III/IV CLINICAL TRIALS: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
CLINICIAN GLOBAL IMPRESSION OF SEVERITY AND CHANGE SCALES FOR CUTANEOUS LUPUS ERYTHEMATOSUS: COGNITIVE DEBRIEFING EVIDENCE SUPPORTING CLINICAL UTILITY
Aug 11, 2026, 17:16 PM -
TOWARD AI-AUGMENTED SCREENING FOR HTA-RELEVANT EVIDENCE SYNTHESIS: VALIDATION OF A GOVERNED SINGLE-REVIEWER WORKFLOW
Aug 11, 2026, 17:16 PM -
CHARACTERIZING RESMETIROM INITIATORS IN THE IMMEDIATE POST-APPROVAL PERIOD: ADHERENCE AND PERSISTENCE, AND HEALTHCARE COSTS FROM A US CLAIMS DATABASE
Aug 11, 2026, 17:16 PM -
REAL-WORLD (RW) CLINICAL OUTCOMES AND CORRELATION OF RECURRENCE FREE SURVIVAL (RFS) AND DISTANT METASTASIS SURVIVAL (DMFS) TO OVERALL SURVIVAL (OS) IN RESECTED STAGE III-IV CUTANEOUS MELANOMA
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE USE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) EXACERBATIONS: A RETROSPECTIVE ANALYSIS OF GERMAN CLAIMS DATA
Aug 11, 2026, 17:16 PM -
MAPPING EPIDEMIOLOGICAL EVIDENCE AND PRIMARY MUTATION LANDSCAPE OF LEBER HEREDITARY OPTIC NEUROPATHY USING AI-ENABLED EVIDENCE SYNTHESIS
Aug 11, 2026, 17:16 PM -
ANTIFUNGAL-ASSOCIATED ACUTE KIDNEY INJURY: A DISPROPORTIONALITY ANALYSIS AND SYSTEMATIC REVIEW
Aug 11, 2026, 17:16 PM -
BEYOND THE MARGIN: WHY THE NHS MEAN COST PER QALY MAY EXCEED THE RECENTLY ELEVATED NICE THRESHOLD
Aug 11, 2026, 17:16 PM -
COMPARING GRACE TO CURRENT METHODOLOGIES IN HEALTH AND TRANSPORT ECONOMICS - APPLICATION TO NONFATAL ROAD TRAFFIC INJURIES BASED ON RISK PREFERENCES AMONG THE SWEDISH GENERAL POPULATION
Aug 11, 2026, 17:16 PM
